Urinary sodium and potassium excretion and CKD progression

Journal of the American Society of Nephrology

Volumn 27, Issue 4, 2016, Pages 1202-1212

  He, Jiang ^a,b   Mills, Katherine T ^a   Appel, Lawrence J ^c   Yang, Wei ^d   Chen, Jing ^a,b   Lee, Belinda T ^b   Rosas, Sylvia E ^d   Porter, Anna ^e   Makos, Gail ^f   Weir, Matthew R ^g   Hamm, L Lee ^a,b   Kusek, John W ^h  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

^f ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; SODIUM;

ADULT; ALL CAUSE MORTALITY; ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SODIUM URINE LEVEL; MORTALITY; URINE;

DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; POTASSIUM; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SODIUM;

EID: 85017072679     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010022     Document Type: Article

References (37)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047, 2007
2. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW: Chronic kidney disease: Global dimension and perspectives. Lancet 382: 260–272, 2013
3. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M; Intersalt Cooperative Research Group: Intersalt revisited: Further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 312: 1249–1253, 1996
4. He FJ, Li J, Macgregor GA: Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 346: f1325, 2013
5. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277: 1624–1632, 1997
6. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK: Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 282: 2027–2034, 1999
7. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK: Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334: 885–888, 2007
8. O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE: Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306: 2229–2238, 2011
9. O’Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, Rosengren A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Yusoff K, Iqbal R, Ilow R, Mohammadifard N, Gulec S, Yusufali AH, Kruger L, Yusuf R, Chifamba J, Kabali C, Dagenais G, Lear SA, Teo K, Yusuf S; PURE Investigators: Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 371: 612–623, 2014
10. IOM (Institute of Medicine): Sodium Intake in Populations: Assessment of Evidence, Washington, DC, National Academies Press, 2013
11. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Groop PH; FinnDiane Study Group: The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34: 861–866, 2011
12. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P: Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 23: 165–173, 2012
13. Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators: Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med 173: 1682–1692, 2013
14. Smyth A, Dunkler D, Gao P, Teo KK, Yusuf S, O’Donnell MJ, Mann JF, Clase CM; ONTARGET and TRANSCEND investigators: The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int 86: 1205–1212, 2014
15. Fan L, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ: Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int 86: 582–588, 2014
16. Liu K, Cooper R, McKeever J, McKeever P, Byington R, Soltero I, Stamler R, Gosch F, Stevens E, Stamler J: Assessment of the association between habitual salt intake and high blood pressure: Methodological problems. Am J Epidemiol 110: 219–226, 1979
17. Lambers Heerspink HJ, Holtkamp FA, Parving HH, Navis GJ, Lewis JB, Ritz E, de Graeff PA, de Zeeuw D: Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 82: 330–337, 2012
18. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP: Effect of increased potassium intake on cardiovascular risk factors and disease: Systematic review and meta-analyses. BMJ 346: f1378, 2013
19. Weir MR, Rolfe M: Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol 5: 531–548, 2010
20. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169: 1156–1162, 2009
21. Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, Kotanko P, Pitt B, Saran R: Serum potassium and outcomes in CKD: Insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol 5: 762–769, 2010
22. Sandle GI, Gaiger E, Tapster S, Goodship THJ: Enhanced rectal potassium secretion in chronic renal insufficiency: Evidence for large intestinal potassium adaptation in man. Clin Sci (Lond) 71: 393–401, 1986
23. Palacios C, Wigertz K, Martin BR, Braun M, Pratt JH, Peacock M, Weaver CM: Racial differences in potassium homeostasis in response to differences in dietary sodium in girls. Am J Clin Nutr 91: 597–603, 2010
24. Cogswell ME, Zhang Z, Carriquiry AL, Gunn JP, Kuklina EV, Saydah SH, Yang Q, Moshfegh AJ: Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr 96: 647–657, 2012
25. Aaron KJ, Campbell RC, Judd SE, Sanders PW, Muntner P: Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Clin Nutr 94: 1071–1078, 2011
26. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA: Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: A randomized control trial. Hypertension 46: 308–312, 2005
27. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell KL: A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol 24: 2096–2103, 2013
28. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 4: 1302–1311, 2009
29. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
30. Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators: Association of kidney disease outcomes with risk factors for CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 63: 236–243, 2014
31. Anderson AH, Yang W, Hsu CY, Joffe MM, Leonard MB, Xie D, Chen J, Greene T, Jaar BG, Kao P, Kusek JW, Landis JR, Lash JP, Townsend RR, Weir MR, Feldman HI; CRIC Study Investigators: Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 60: 250–261, 2012
32. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC: Dietary fat and coronary heart disease: A comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149: 531–540, 1999
33. Hosmer DW, Lemeshow S, May S: Applied Survival Analysis: Regression Modeling Of Time-To-Event Data, 2nd Ed., Hoboken, NJ, John Wiley & Sons, Inc., 2008
34. Cox DR: Regression models and life tables (with discussion). JR Stat Soc Series B 34: 187–220, 1972
35. Friedman JH: Multivariate adaptive regression splines. Ann Stat 19: 1–67, 1991
36. Wilson FP, Xie D, Anderson AH, Leonard MB, Reese PP, Delafontaine P, Horwitz E, Kallem R, Navaneethan S, Ojo A, Porter AC, Sondheimer JH, Sweeney HL, Townsend RR, Feldman HI; CRIC Study Investigators: Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: The CRIC study. Clin J Am Soc Nephrol 9: 2095–2103, 2014
37. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3: 1–150, 2013